Cargando…

In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study

Traumatic brain injury causes diffuse axonal injury and loss of cortical neurons. These features are well recognized histologically, but their in vivo monitoring remains challenging. In vivo cortical microdialysis samples the extracellular fluid adjacent to neurons and axons. Here, we describe a nov...

Descripción completa

Detalles Bibliográficos
Autores principales: Petzold, Axel, Tisdall, Martin M., Girbes, Armand R., Martinian, Lillian, Thom, Maria, Kitchen, Neil, Smith, Martin
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3030768/
https://www.ncbi.nlm.nih.gov/pubmed/21278408
http://dx.doi.org/10.1093/brain/awq360
_version_ 1782197290955440128
author Petzold, Axel
Tisdall, Martin M.
Girbes, Armand R.
Martinian, Lillian
Thom, Maria
Kitchen, Neil
Smith, Martin
author_facet Petzold, Axel
Tisdall, Martin M.
Girbes, Armand R.
Martinian, Lillian
Thom, Maria
Kitchen, Neil
Smith, Martin
author_sort Petzold, Axel
collection PubMed
description Traumatic brain injury causes diffuse axonal injury and loss of cortical neurons. These features are well recognized histologically, but their in vivo monitoring remains challenging. In vivo cortical microdialysis samples the extracellular fluid adjacent to neurons and axons. Here, we describe a novel neuronal proteolytic pathway and demonstrate the exclusive neuro-axonal expression of Pavlov’s enterokinase. Enterokinase is membrane bound and cleaves the neurofilament heavy chain at positions 476 and 986. Using a 100 kDa microdialysis cut-off membrane the two proteolytic breakdown products, extracellular fluid neurofilament heavy chains NfH(476−986) and NfH(476−1026), can be quantified with a relative recovery of 20%. In a prospective clinical in vivo study, we included 10 patients with traumatic brain injury with a median Glasgow Coma Score of 9, providing 640 cortical extracellular fluid samples for longitudinal data analysis. Following high-velocity impact traumatic brain injury, microdialysate extracellular fluid neurofilament heavy chain levels were significantly higher (6.18 ± 2.94 ng/ml) and detectable for longer (>4 days) compared with traumatic brain injury secondary to falls (0.84 ± 1.77 ng/ml, <2 days). During the initial 16 h following traumatic brain injury, strong correlations were found between extracellular fluid neurofilament heavy chain levels and physiological parameters (systemic blood pressure, anaerobic cerebral metabolism, excessive brain tissue oxygenation, elevated brain temperature). Finally, extracellular fluid neurofilament heavy chain levels were of prognostic value, predicting mortality with an odds ratio of 7.68 (confidence interval 2.15–27.46, P = 0.001). In conclusion, this study describes the discovery of Pavlov’s enterokinase in the human brain, a novel neuronal proteolytic pathway that gives rise to specific protein biomarkers (NfH(476−986) and Nf(H476−1026)) applicable to in vivo monitoring of diffuse axonal injury and neuronal loss in traumatic brain injury.
format Text
id pubmed-3030768
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-30307682011-09-28 In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study Petzold, Axel Tisdall, Martin M. Girbes, Armand R. Martinian, Lillian Thom, Maria Kitchen, Neil Smith, Martin Brain Original Articles Traumatic brain injury causes diffuse axonal injury and loss of cortical neurons. These features are well recognized histologically, but their in vivo monitoring remains challenging. In vivo cortical microdialysis samples the extracellular fluid adjacent to neurons and axons. Here, we describe a novel neuronal proteolytic pathway and demonstrate the exclusive neuro-axonal expression of Pavlov’s enterokinase. Enterokinase is membrane bound and cleaves the neurofilament heavy chain at positions 476 and 986. Using a 100 kDa microdialysis cut-off membrane the two proteolytic breakdown products, extracellular fluid neurofilament heavy chains NfH(476−986) and NfH(476−1026), can be quantified with a relative recovery of 20%. In a prospective clinical in vivo study, we included 10 patients with traumatic brain injury with a median Glasgow Coma Score of 9, providing 640 cortical extracellular fluid samples for longitudinal data analysis. Following high-velocity impact traumatic brain injury, microdialysate extracellular fluid neurofilament heavy chain levels were significantly higher (6.18 ± 2.94 ng/ml) and detectable for longer (>4 days) compared with traumatic brain injury secondary to falls (0.84 ± 1.77 ng/ml, <2 days). During the initial 16 h following traumatic brain injury, strong correlations were found between extracellular fluid neurofilament heavy chain levels and physiological parameters (systemic blood pressure, anaerobic cerebral metabolism, excessive brain tissue oxygenation, elevated brain temperature). Finally, extracellular fluid neurofilament heavy chain levels were of prognostic value, predicting mortality with an odds ratio of 7.68 (confidence interval 2.15–27.46, P = 0.001). In conclusion, this study describes the discovery of Pavlov’s enterokinase in the human brain, a novel neuronal proteolytic pathway that gives rise to specific protein biomarkers (NfH(476−986) and Nf(H476−1026)) applicable to in vivo monitoring of diffuse axonal injury and neuronal loss in traumatic brain injury. Oxford University Press 2011-02 2011-01-27 /pmc/articles/PMC3030768/ /pubmed/21278408 http://dx.doi.org/10.1093/brain/awq360 Text en © The Author(s) 2011. Published by Oxford University Press on behalf of Brain. http://creativecommons.org/licenses/by-nc/2.5 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Petzold, Axel
Tisdall, Martin M.
Girbes, Armand R.
Martinian, Lillian
Thom, Maria
Kitchen, Neil
Smith, Martin
In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study
title In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study
title_full In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study
title_fullStr In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study
title_full_unstemmed In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study
title_short In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study
title_sort in vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3030768/
https://www.ncbi.nlm.nih.gov/pubmed/21278408
http://dx.doi.org/10.1093/brain/awq360
work_keys_str_mv AT petzoldaxel invivomonitoringofneuronallossintraumaticbraininjuryamicrodialysisstudy
AT tisdallmartinm invivomonitoringofneuronallossintraumaticbraininjuryamicrodialysisstudy
AT girbesarmandr invivomonitoringofneuronallossintraumaticbraininjuryamicrodialysisstudy
AT martinianlillian invivomonitoringofneuronallossintraumaticbraininjuryamicrodialysisstudy
AT thommaria invivomonitoringofneuronallossintraumaticbraininjuryamicrodialysisstudy
AT kitchenneil invivomonitoringofneuronallossintraumaticbraininjuryamicrodialysisstudy
AT smithmartin invivomonitoringofneuronallossintraumaticbraininjuryamicrodialysisstudy